A potent and selectiveinhibitor of the anticancer target Polo‐likekinase1 was found by computer‐based molecular design. This type II kinaseinhibitor was synthesized as suggested by the design software DOGS and exhibited significant antiproliferative effects against HeLa cells without affecting nontransformed cells. The study provides a proof‐of‐concept for reaction‐based de novo design as a leading